Allergan Plc Acquires Akarna Therapeutics for $50,000,000

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=09884060-054d-4889-9429-c602b138d3a2
Date
9/21/2016
Company Name
Akarna Therapeutics
Mailing Address
1012 Second Street Encinitas, CA 92007 USA
Company Description
Akarna Therapeutics is a biopharmaceutical company developing novel small molecule therapeutics that target inflammatory and fibrotic diseases for which there is no approved treatment.
Website
http://www.akarna.com
Transaction Type
M&A
Transaction Amount
$50,000,000
Transaction Round
Proceeds Purposes
M&A Terms
Under the terms of the agreement, Allergan acquired Akarna for an upfront cash payment of $50 million and success-based development, regulatory and sales milestones.